We are excited to congratulate Stephen Jones, who has recently been promoted within the Medical Marijuana, Inc. executive team to take on the additional role of President of HempMeds®.
Also remaining in his CMO role, Jones is ready to make a positive impact on HempMeds® operations with his extensive marketing knowledge and executive experience. HempMeds® is a rapidly growing company in a booming CBD market.
Reports reveal that hemp-derived CBD products generated $170 million in revenue in 2016. An estimated 55 percent compound annual growth rate will cause the market to explode to $1 billion to $2 billion by 2020, making it an important factor in the future growth of the cannabis market.
Reports reveal that hemp-derived CBD products generated $170 million in revenue in 2016. An estimated 55 percent compound annual growth rate will cause the market to explode to $1 billion to $2 billion by 2020, making it an important factor in the future growth of the cannabis market.
“I’m absolutely thrilled about this new leadership opportunity within the Medical Marijuana, Inc. portfolio of companies,” said Jones. “HempMeds is a company with a rich background as one of the companies that helped create the hemp CBD industry and has helped people all over the world with our innovative product lines. I’m excited to play a role in strengthening the HempMeds® brand and continuing to develop the Company as the market for CBD products continues to expand across the globe.”
HempMeds® is a pioneer in the CBD industry, shipping their award-winning line of CBD supplements to all 50 states and over 40 countries internationally. The company’s Real Scientific Hemp Oil™ brand was the first legal cannabis product authorized for use in Brazil, Mexico, Paraguay, and the American territory of Puerto Rico.
In his new role as President of HempMeds®, Jones will manage the company’s daily operations, focusing on continued domestic growth and further international market expansion. Jones, who has experience in product development and marketing, plans to launch innovative new product offerings to keep HempMeds® among the industry leaders in CBD. He will also guide the company as it pursues new markets in Europe and Latin America for HempMeds® CBD oil products.
Jones originally joined Medical Marijuana, Inc. in September 2017 as Chief Marketing Officer, bringing nearly two decades of experience in direct sales, finance, and international logistics to the company and its subsidiaries.
Jones will take on a dual role with Medical Marijuana, Inc., where he will remain Chief Marketing Officer, overseeing the company’s marketing goals across its portfolio of hemp products and brands and generating long-term growth.
“We are excited to have Mr. Jones step up and take on more responsibility in the Company and continue to provide insightful creative and strategic direction,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “Since joining our organization, he has helped the Company find a clear brand voice and we think that HempMeds® can definitely benefit from this type of leadership.”
You can find more developments from the Medical Marijuana, Inc. family of companies on our news feed.
credit:medicalmarijuanainc.com
